Mobidiag, a Finnish biotech, has launched a diagnostic test that can rapidly detect the most common disease-causing microbes in the gut. The test can help manage infections more effectively at an earlier stage.
Mobidiag has launched a molecular diagnostic test on the European market that checks patient samples for numerous bacterial targets, including the most common bacteria causing diarrhea. The technology speeds up the diagnostic process by providing results in around an hour, while conventional diagnostics using cell culture take several days.
Read more: https://labiotech.eu/mobidiag-diagnostic-test-launch/